CytomX Therapeutics Inc
NASDAQ:CTMX
Income Statement
Earnings Waterfall
CytomX Therapeutics Inc
Revenue
|
101.2m
USD
|
Operating Expenses
|
-107.7m
USD
|
Operating Income
|
-6.5m
USD
|
Other Expenses
|
5.9m
USD
|
Net Income
|
-569k
USD
|
Income Statement
CytomX Therapeutics Inc
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
5
N/A
|
6
+21%
|
8
+22%
|
8
+0%
|
8
+2%
|
8
+6%
|
9
+13%
|
11
+16%
|
15
+40%
|
24
+63%
|
30
+23%
|
51
+69%
|
72
+41%
|
74
+4%
|
87
+17%
|
75
-13%
|
60
-21%
|
75
+26%
|
62
-16%
|
61
-3%
|
58
-5%
|
78
+35%
|
85
+10%
|
92
+8%
|
100
+9%
|
67
-34%
|
66
0%
|
66
0%
|
37
-44%
|
30
-19%
|
27
-11%
|
21
-24%
|
53
+159%
|
48
-9%
|
60
+24%
|
76
+25%
|
101
+34%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(35)
|
(24)
|
(26)
|
(34)
|
(41)
|
(53)
|
(62)
|
(68)
|
(75)
|
(76)
|
(93)
|
(110)
|
(118)
|
(127)
|
(128)
|
(128)
|
(137)
|
(154)
|
(159)
|
(160)
|
(168)
|
(175)
|
(167)
|
(163)
|
(149)
|
(128)
|
(131)
|
(138)
|
(153)
|
(163)
|
(170)
|
(171)
|
(147)
|
(143)
|
(128)
|
(110)
|
(108)
|
|
Selling, General & Administrative |
(7)
|
(7)
|
(8)
|
(11)
|
(13)
|
(16)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(23)
|
(26)
|
(27)
|
(30)
|
(32)
|
(34)
|
(36)
|
(36)
|
(37)
|
(37)
|
(37)
|
(36)
|
(36)
|
(36)
|
(36)
|
(36)
|
(39)
|
(39)
|
(40)
|
(43)
|
(42)
|
(40)
|
(40)
|
(36)
|
(32)
|
(30)
|
|
Research & Development |
(28)
|
(17)
|
(18)
|
(23)
|
(28)
|
(37)
|
(45)
|
(49)
|
(55)
|
(56)
|
(71)
|
(87)
|
(92)
|
(100)
|
(98)
|
(96)
|
(104)
|
(118)
|
(123)
|
(124)
|
(132)
|
(138)
|
(131)
|
(127)
|
(113)
|
(93)
|
(95)
|
(100)
|
(114)
|
(122)
|
(127)
|
(129)
|
(106)
|
(102)
|
(92)
|
(78)
|
(78)
|
|
Operating Income |
(30)
N/A
|
(18)
+40%
|
(19)
-4%
|
(26)
-42%
|
(33)
-26%
|
(45)
-34%
|
(53)
-20%
|
(57)
-7%
|
(60)
-5%
|
(52)
+13%
|
(63)
-21%
|
(59)
+6%
|
(46)
+22%
|
(53)
-15%
|
(41)
+23%
|
(53)
-30%
|
(78)
-46%
|
(79)
-1%
|
(97)
-23%
|
(99)
-3%
|
(111)
-12%
|
(97)
+12%
|
(82)
+16%
|
(71)
+13%
|
(49)
+32%
|
(61)
-26%
|
(65)
-5%
|
(72)
-12%
|
(116)
-61%
|
(132)
-14%
|
(143)
-8%
|
(150)
-5%
|
(94)
+38%
|
(94)
-1%
|
(67)
+28%
|
(35)
+49%
|
(6)
+81%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
6
|
8
|
9
|
10
|
9
|
8
|
7
|
5
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
6
|
8
|
10
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(30)
N/A
|
(20)
+36%
|
(20)
-4%
|
(29)
-41%
|
(35)
-24%
|
(45)
-28%
|
(54)
-19%
|
(56)
-5%
|
(59)
-5%
|
(51)
+13%
|
(62)
-22%
|
(58)
+7%
|
(44)
+25%
|
(50)
-14%
|
(36)
+27%
|
(47)
-29%
|
(70)
-50%
|
(70)
+0%
|
(87)
-25%
|
(90)
-3%
|
(103)
-14%
|
(90)
+12%
|
(77)
+15%
|
(68)
+12%
|
(47)
+31%
|
(61)
-30%
|
(64)
-6%
|
(72)
-12%
|
(116)
-61%
|
(132)
-14%
|
(143)
-8%
|
(149)
-5%
|
(99)
+33%
|
(90)
+10%
|
(61)
+32%
|
(27)
+57%
|
3
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
(1)
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
(26)
|
(28)
|
(31)
|
(14)
|
(13)
|
(11)
|
(9)
|
0
|
14
|
14
|
14
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
|
Income from Continuing Operations |
(30)
|
(21)
|
(20)
|
(29)
|
(35)
|
(44)
|
(54)
|
(56)
|
(59)
|
(51)
|
(62)
|
(58)
|
(69)
|
(76)
|
(64)
|
(77)
|
(85)
|
(83)
|
(99)
|
(99)
|
(102)
|
(76)
|
(63)
|
(54)
|
(33)
|
(61)
|
(64)
|
(72)
|
(116)
|
(132)
|
(143)
|
(149)
|
(99)
|
(90)
|
(61)
|
(29)
|
(1)
|
|
Net Income (Common) |
(35)
N/A
|
(24)
+30%
|
(26)
-6%
|
(36)
-39%
|
(42)
-17%
|
(50)
-20%
|
(57)
-13%
|
(57)
+0%
|
(59)
-3%
|
(51)
+13%
|
(62)
-22%
|
(58)
+7%
|
(43)
+25%
|
(50)
-17%
|
(39)
+23%
|
(52)
-34%
|
(85)
-63%
|
(83)
+2%
|
(99)
-19%
|
(99)
0%
|
(102)
-3%
|
(76)
+26%
|
(63)
+17%
|
(54)
+14%
|
(33)
+39%
|
(61)
-84%
|
(64)
-6%
|
(72)
-12%
|
(116)
-61%
|
(132)
-14%
|
(143)
-8%
|
(149)
-5%
|
(99)
+33%
|
(90)
+10%
|
(61)
+32%
|
(29)
+52%
|
(1)
+98%
|
|
EPS (Diluted) |
-1
N/A
|
-0.71
+29%
|
-0.76
-7%
|
-0.99
-30%
|
-4.9
-395%
|
-1.39
+72%
|
-1.58
-14%
|
-1.56
+1%
|
-1.63
-4%
|
-1.41
+13%
|
-1.71
-21%
|
-1.56
+9%
|
-1.15
+26%
|
-1.3
-13%
|
-0.98
+25%
|
-1.17
-19%
|
-2.03
-74%
|
-1.84
+9%
|
-2.17
-18%
|
-2.19
-1%
|
-2.26
-3%
|
-1.67
+26%
|
-1.37
+18%
|
-1.17
+15%
|
-0.71
+39%
|
-0.99
-39%
|
-0.98
+1%
|
-1.1
-12%
|
-1.81
-65%
|
-2.04
-13%
|
-2.19
-7%
|
-2.28
-4%
|
-1.51
+34%
|
-1.36
+10%
|
-0.93
+32%
|
-0.36
+61%
|
-0.01
+97%
|